医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Berkshire Hathaway Specialty Insurance Promotes Edwin Sim to Lead Executive & Professional Lines in Singapore

2023年09月05日 AM10:15
このエントリーをはてなブックマークに追加


 

BOSTON & SINGAPORE

Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has named Edwin Sim as Vice President and Head of Executive & Professional Lines in Singapore.

“Our Executive & Professional Lines capabilities continue to expand in Singapore and throughout Asia. Edwin has been integral to this expansion, while also delivering BHSI holistically, with multi-line solutions and multinational programs, to our customers and brokers throughout the region,” said Scotland Walsh-Riddle, Regional Head of Executive & Professional Lines, Asia, BHSI. “I look forward to working with Edwin and our stellar Singapore team to bring our expansive, simply worded policies and customized Executive & Professional Lines capacity to the marketplace.”

Edwin joined BHSI in 2017 as Assistant Vice President, Executive & Professional Lines in Singapore, and was promoted to Vice President, Executive & Professional Lines in Singapore in 2020. He has more than 25 years of industry experience focused on financial lines. Edwin continues to be based in Singapore and can be reached at Edwin.Sim@bhspecialty.com.

Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident and health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. In the Asia Middle East region, it underwrites on the paper of Berkshire Hathaway Specialty Insurance Company, which holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor’s. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Cologne, Dubai, Dublin, Frankfurt, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Munich, Paris, Perth, Singapore, Sydney, Toronto, and Zurich.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230904590744/en/

CONTACT

MEDIA

JoAnn Lee / +1 617.936.2937

同じカテゴリーの記事 

  • Avistone Announces Results from a Sponsored Clinical Research Program Studying the Combination of Two Small-Molecule c-MET and EGFR Inhibitors in NSCLC Patients at the 2024 World Conference on Lung Cancer (WCLC)
  • CorFlow Therapeutics AG完成4400万欧元B轮融资,以支持发展针对心脏病发作患者微血管阻塞(MVO)的新型诊断和药物递送平台
  • 诺为泰凭借其生物技术CRO服务方面的领导力荣膺Frost & Sullivan“2024全球年度公司奖”
  • CorFlow Therapeutics AG、心臓発作患者における微小血管閉塞(MVO)の新規診断・薬物送達プラットフォームの開発を支援するため4400万ユーロのシリーズB資金調達を完了
  • New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphataemia (XLH)